International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia
J Rello, JA Paiva, J Baraibar, F Barcenilla, M Bodi… - Chest, 2001 - Elsevier
Ventilator-associated pneumonia (VAP) is an important health problem that still generates
great controversy. A consensus conference attended by 12 researchers from Europe and …
great controversy. A consensus conference attended by 12 researchers from Europe and …
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
…, T Le Voyer, J Rosain, Q Philippot, J Manry… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais… - Proceedings of the …, 2022 - National Acad Sciences
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR)
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …
Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort
…, J Solé-Violan, FS Sipmann, LT Lomas, J Trenado - Chest, 2021 - Elsevier
Background More than 20% of hospitalized patients with COVID-19 demonstrate ARDS
requiring ICU admission. The long-term respiratory sequelae in such patients remain unclear. …
requiring ICU admission. The long-term respiratory sequelae in such patients remain unclear. …
[HTML][HTML] Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre …
…, J Solé-Violán, E Díaz, J Gómez… - The Lancet Regional …, 2021 - thelancet.com
Background It is unclear whether the changes in critical care throughout the pandemic have
improved the outcomes in coronavirus disease 2019 (COVID-19) patients admitted to the …
improved the outcomes in coronavirus disease 2019 (COVID-19) patients admitted to the …
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with …
…, M Sa-Borges, J Sole-Violan… - Critical care …, 2007 - journals.lww.com
Objective: To evaluate whether one antibiotic achieves equal outcomes compared with
combination antibiotic therapy in patients with Pseudomonas aeruginosa ventilator-associated …
combination antibiotic therapy in patients with Pseudomonas aeruginosa ventilator-associated …
Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units
…, J Sole-Violan, E Diaz, A Topeli, J DeWaele… - Critical care …, 2009 - journals.lww.com
Objectives: Information on clinical practice regarding the diagnosis of pneumonia in European
intensive care units is limited. The aim of this study was to describe the spectrum of actual …
intensive care units is limited. The aim of this study was to describe the spectrum of actual …
Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on …
…, J Garnacho, J Blanquer, J Jimenez… - Clinical Infectious …, 2005 - academic.oup.com
Background . The purpose of our study was to analyze prognostic factors associated with
mortality for patients with severe community-acquired pneumonia (CAP). Methods . We …
mortality for patients with severe community-acquired pneumonia (CAP). Methods . We …
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
…, T Le Voyer, L Bizien, J Manry, J Rosain… - Journal of Experimental …, 2022 - rupress.org
Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19
pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring …
pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring …
Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
…, A Torres, J Roig, J Sole-Violan… - European …, 2006 - Eur Respiratory Soc
The mortality rate of chronic obstructive pulmonary disease (COPD) patients with community-acquired
pneumonia (CAP) is reported to be low. However, studies carried out to date have …
pneumonia (CAP) is reported to be low. However, studies carried out to date have …